Healthcare -
Biotechnology - NASDAQ - US
$ 0.91
9 %
$ 49.6 M
Market Cap
11.38
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--10.69%
EBIT
Estimate
--49.40%
Net Income
Estimate
7.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Spero Therapeutics, Inc.
SPRO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SPRO
EBIT FORECAST
EBIT Forecast Chart SPRO
NET INCOME FORECAST
Net Income Chart SPRO